Leaderboard

En | De
Sie sind hier: Gastroenterologie » Oesophagus » Neoplasie 24. Oktober 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Motilitätsstörungen
Neoplasie
Anderes
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 1997  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 39925  
   
Lymph Node Regression Improves Prognostic Stratification in Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Cohort Study.
MedComm (2020)
Zheng J, Shen W, Cao J, Gao L, Zan L, Zhang T, Gong L, Duan X, Wang X, Wu Y, Tang P, Jiang H, Pang Q, Zhao G, Zhang W, Yan C.
PMID: 42910074 [PubMed]


Esophageal Carcinoma Incidence and Survival Analysis: A Population-Based Cancer Registry Study in Central India.
Cureus
Ghongade PV, Patil BU, Gupta A, Maliye S, Gangane N.
PMID: 42909884 [PubMed]


Visualizing the distribution of durvalumab targeting PD-L1 using quantitative fluorescence imaging in patients with esophageal cancer.
Theranostics
van der Waaij AM, van Ginkel YJ, Volkmer P, Kats-Ugurlu G, Huizinga HK, Hone Lopez S, de Haan JJ, Bijlsma R, van der Waaij LA, Muijs CT, Niezink AGH, van Etten B, Westerhof J, di Pietro M, Robinson DJ, Lub-de Hooge MN, Nagengast WB.
PMID: 42909237 [PubMed - indexed for MEDLINE]


Survival outcomes and safety of adding high-dose-rate intraluminal brachytherapy (HDR-ILBT) utilizing the novel balloon applicator (BRAXX) following concurrent chemoradiotherapy (CCRT) for non-surgical esophageal cancer: a prospective pilot and real-world comparative study.
Am J Cancer Res
Chen SH, Kao WH, Tsan DL, Yap WK, Hung TM, Chen MF, Pai PC, Lin AC, Lu WH, Tseng CK.
PMID: 42908863 [PubMed]


Efficacy of tislelizumab combined with nab-paclitaxel and nedaplatin in advanced esophageal squamous cell carcinoma and its impact on serum tumor markers.
Am J Cancer Res
Huang R, Shen G, Zhang W, Lin Y, Huang Z, Dai Y, Lin Y, Zhang Y.
PMID: 42908730 [PubMed]


Underweight Versus Obesity and Gastrointestinal Cancer Mortality in Type 2 Diabetes: A Nationwide Cohort Study.
J Cachexia Sarcopenia Muscle
Park JH, Han K, Choe HJ, Park SE, Lee WY, Moon SJ, Rhee EJ.
PMID: 42908126 [PubMed - indexed for MEDLINE]


Misreporting of study design and validation status in a study of early tumour shrinkage in esophageal squamous cell carcinoma.
Cancer Imaging
Khodamoradi E.
PMID: 42907938 [PubMed - indexed for MEDLINE]


Acetic acid chromoendoscopy for detection of neoplastic Barrett's oesophagus: stepped wedge cluster randomised controlled trial (ACID-trial).
BMJ
Beaufort IN, Boer LS, Milne AN, Alderlieste YA, Baars JE, Bos PR, Burger JPW, van Heel NCM, Ledeboer M, Lieverse RJ, van de Meeberg PC, Meeuse JJ, Naber AHJ, Pullens HJM, Scheffer RCH, Sikkema M, Stolk MFJ, Verbeek RE, Verhagen MAMT, van de Vrie W, Willems M, van Werkhoven CH, Weusten BLAM.
PMID: 42907095 [PubMed - indexed for MEDLINE]


A dual-prompt framework combining spatial-mask priors and clinical-text conditioning for CT-only GTV delineation in esophageal cancer: A multicenter study.
Med Phys
Sun H, Chen C, Chen J, Wang Q, Li J, An Z, Liu Y, Meng F, Jia L, Shi Z, Cui Y, Liu Y, Gong J, Huang D, Zhao L.
PMID: 42905882 [PubMed - indexed for MEDLINE]


Molecular mechanisms and therapeutic strategies of immunotherapy resistance in esophageal cancer.
Front Immunol
Pang Y, Jiang P, Liu K, Suo X, Zhang D, Xu Y, Ge Y, Fu Q, Gao S.
PMID: 42903418 [PubMed - indexed for MEDLINE]


Can Current Innovations in Diagnostic and Therapeutic Strategies Transform Gastroesophageal Cancer Care?
Middle East J Dig Dis
Alshwayyat S, Almasri N, Maraqa K, Abu Samrah S, Aljawabrah S, Abuhalaweh N, Alshwaiyat Y, Al-Shami R, Al-Zoubi L, Alswaiti Y, Altaweel H, Abid R, Alqasem K, Al-Kurdi MA.
PMID: 42903379 [PubMed]


Immune-related adverse events are associated with favorable clinical outcomes in esophageal cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Front Oncol
Fan J, Chen D, Jia L.
PMID: 42903106 [PubMed]


Study protocol of a prospective, non-interventional cohort study evaluating the benefits of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma receiving first-line atezolizumab plus bevacizumab (NISTIPS TRITICC-4, IKF092).
Future Oncol
Angendohr C, Weigel C, Kunstein A, Joerdens M, Goetze T, Al-Batran SE, Zäpf B, Gonzalez-Carmona M, Sahin C, Berres ML, Foerster F, Ben Khaled N, Koch C, Kandulski A, Wege H, Trebicka J, Jochheim LS, Dill MT, Springfeld C, Daum S, Treese C, Ehmer U, Luedde T, Bode J, Roderburg C.
PMID: 42902603 [PubMed - as supplied by publisher]


Eosinophilic Oesophagitis and Incidence of Gastrointestinal Cancer: A Population-Based Cohort Study.
Aliment Pharmacol Ther
Kurt G, Farkas DK, Dellon ES, Jensen ET, Sørensen HT.
PMID: 42902446 [PubMed - as supplied by publisher]


Effectiveness of personalized positioning management in preventing hypoxemia during sedated endoscopy: a retrospective study.
BMC Gastroenterol
Chen Y, Zhu J.
PMID: 42902208 [PubMed - indexed for MEDLINE]


Combined TIPS and TACE for patients with hepatocellular carcinoma and variceal bleeding secondary to portal vein tumor thrombus.
BMC Gastroenterol
Feng Z, Wu B, Xu Z, Yang W, Zhou H, Shi H, Liu S, Zhou W.
PMID: 42902152 [PubMed - indexed for MEDLINE]


Ociperlimab and tislelizumab in advanced esophageal squamous cell carcinoma (AdvanTIG-203): a phase II study.
Nat Commun
Wang F, Lin CY, Sun JM, Lu CH, Zhu X, Chen Z, Zhao Q, Kim IH, Pan Y, Zhang J, Chen Z, Tougeron D, Kim SB, Van Cutsem E, Zaanan A, Rivera F, Dechaphunkul A, Zuo Y, Wan Q, Zhang J, Zhou J, Xu RH.
PMID: 42901884 [PubMed - indexed for MEDLINE]


Management of cT2N0M0 esophageal cancer: a systematic review and meta-analysis.
Dis Esophagus
Eliya Y, Leng S, Litle VR, Asghari M, Kohn GP.
PMID: 42900766 [PubMed - indexed for MEDLINE]


Prognostic analysis of remarkable response after radiotherapy or chemoradiotherapy in esophageal cancer.
Dis Esophagus
Nishiue K, Hayashi Y, Sugioka H, Yoneda S, Adachi Y, Tajiri A, Fukuda H, Kimura E, Uema R, Yoshihara T, Tsujii Y, Makino T, Doki Y, Kodama T.
PMID: 42900765 [PubMed - indexed for MEDLINE]


Gut microbiota in esophageal cancer: mechanisms, clinical implications, and therapeutic potential.
Front Microbiol
Li Y, Zhou L, Huang R, Wang Y, Zhao H, Sun M, Zhang Y, Wu Z, Li J.
PMID: 42898827 [PubMed]


   
   Artikel 1 - 20 / 39925    Seite 1 von 1997  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1